Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia
Leukemia & Myelodysplastic Syndromes (MDS)
-
-
Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
-
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
-
Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
-
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia
-
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
-
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
-
Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
-
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
-
Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720
Categories
Alliance Committee
Browse by Year